Table 3.

Summary of Continuous Glucose Monitoring Data.

Case	Mean glucose concentration, (mg/dL)		Maximum glucose concentration, (mg/dL)		Minimum glucose concentration, (mg/dL)		SD(mg/dL)		MAGE(mg/dL)		24 h AUC>180 (mg·24h/dL)		24 h AOC<70 (mg·24h/dL)
	Before	After	Before	After	Before	After	Before	After	Before	After	Before	After	Before	After
1	152.5	141.2	303	296	40	40	61.7	58.0	172.0	179.0	310.9	187.6	10.3	14.7
2	138.0	118.6	223	193	82	77	26.8	25.4	80.8	75.5	58.6	2.3	0.0	0.0
3	127.1	115.7	191	208	59	76	45.8	25.8	144.1	78.5	94.1	6.2	2.1	0.0
4	111.6	108.4	260	194	40	63	49.9	35.9	144.8	104.1	38.0	5.9	100.9	6.1
5	138.2	127.6	244	242	64	59	49.0	44.8	136.6	128.1	203.1	76.7	1.6	9.2
6	128.2	115.4	207	208	57	61	32.4	38.7	96.2	107.9	14.6	31.7	9.8	3.0
7	144.7	147.0	278	225	78	79	42.6	32.2	127.3	93.3	141.5	72.0	0.0	0.0
8	136.6	132.1	219	189	92	66	23.4	20.0	63.3	60.0	20.0	4.1	0.0	0.7
9	120.8	120.0	263	238	66	40	47.6	47.0	135.7	138.6	87.0	79.7	2.4	37.7
10	141.3	122.7	268	164	46	79	41.1	13.7	131.3	44.5	108.8	0.0	24.1	0.0
11	196.6	126.8	375	269	95	59	58.0	44.6	163.7	130.9	745.0	64.2	0.0	9.5

After: after DPP-4 inhibitor treatment, AOC: area over the curve, AUC: area under the curve, Before: before DPP-4 inhibitor treatment, MAGE: mean amplitude of glycemic excursion